Pemphigus and pemphigoids: Clinical presentation, diagnosis and therapy
JDDG: Journal der Deutschen Dermatologischen Gesellschaft · 2023
DOI: 10.1111/ddg.15174 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2023. Verfasst von Dario Didona und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Allergology, Philipps-Universität Marburg, Marburg, Germany. Hauptthemen laut MEDLINE: Pemphigus, Pemphigoid, Bullous. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 235 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Pemphigus and pemphigoid are two potentially life‐threatening groups of autoimmune diseases, characterized by autoantibodies targeting structural components of desmosomes or hemidesmosomes, respectively. Affected patients typically show itchy/painful plaques or blistering skin lesions and/or impairing mucosal blistering and erosions, which may strongly impact their quality of life. Since the milestone work of Walter Lever in 1953, who differentiated these two groups of diseases by histopathological analysis of the level of antibody‐mediated skin cleavage, enormous progresses occurred. Achievements made in laboratory diagnostics now allow to identify antigen specific structural proteins of the skin that are targeted by pathogenic autoantibodies. These progresses were accompanied by an increased understanding of the pathogenesis of these diseases thanks to the establishment of animal models reproducing disease and on studies on skin and blood of affected individuals, which have been leading to novel and disease‐specific treatments. Yet, given their phenotypical overlap with more common dermatological diseases, correct diagnosis and appropriate treatment are often delayed, in some cases leading to irreversible sequelae, including organ dysfunction (i.e., loss of vision in mucous membrane pemphigoid). Here, we provide a concise overview of the clinical appearance, diagnosis and therapeutic management of pemphigus and pemphigoid diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology and Allergology, Philipps-Universität Marburg, Marburg, Germany.
- Department of Dermatology and Allergology, University Hospital RWTH Aachen, Aachen, Germany.
- Department of Health Sciences, Section of Dermatology, University of Florence, Florence, Italy.
- Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, BIH Charité Clinician Scientist Program, Germany.
ORCID-Profile: Farzan Solimani
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Didona, D., Schmidt, M. F., Maglie, R., & Solimani, F. (2023). Pemphigus and pemphigoids: Clinical presentation, diagnosis and therapy. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. https://doi.org/10.1111/ddg.15174
Vancouver
Didona D, Schmidt MF, Maglie R, Solimani F. Pemphigus and pemphigoids: Clinical presentation, diagnosis and therapy. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2023. doi:10.1111/ddg.15174
BibTeX
@article{Didona2023,
author = {Didona, Dario and Schmidt, Morna F and Maglie, Roberto and Solimani, Farzan},
title = {Pemphigus and pemphigoids: Clinical presentation, diagnosis and therapy},
journal = {JDDG: Journal der Deutschen Dermatologischen Gesellschaft},
year = {2023},
doi = {10.1111/ddg.15174}
}
EUVIMED